HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression

J Cell Biochem. 2018 Sep;119(9):7226-7234. doi: 10.1002/jcb.26901. Epub 2018 Jun 1.

Abstract

Drug resistance is a big obstacle for clinical anti-tumor treatment outcome. However, the role of HOTAIR in drug resistance in gastric cancer (GC) remains unknown. In this study, we showed that overexpression of HOTAIR enhanced paclitaxel and doxorubicin resistance in GC cells. Furthermore, the expression of HOTAIR was upregulated in GC tissues and higher expression of HOTAIR was associated with late stage. In addition, we showed that miR-217 expression was lower in GC tissues compared with the paired non-tumour tissues and downregulated expression of miR-217 was correlated with late stage. Interestingly, the expression of miR-217 was negatively correlated with HOTAIR expression in GC tissues. Ectopic expression of HOTAIR increased GC cell proliferation, cell cycle, and migration. Elevated expression of HOTAIR suppressed miR-217 expression and enhanced GPC5 and PTPN14 expression. Furthermore, we demonstrated that overexpression of miR-217 suppressed paclitaxel and doxorubicin resistance in GC cells. Ectopic expression of HOTAIR promoted drug resistance and increased GC cell proliferation, cell cycle, and migration by targeting miR-217. These data suggested that overexpression of HOTAIR enhanced paclitaxel and doxorubicin resistance in GC cells through inhibiting miR-217 expression.

Keywords: HOTAIR; doxorubicin; gastric cancer; miR-217; paclitaxel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • China
  • Down-Regulation
  • Doxorubicin / therapeutic use*
  • Drug Resistance, Neoplasm*
  • Ectopic Gene Expression
  • Gene Expression Regulation, Neoplastic
  • Hospitals, University
  • Humans
  • MicroRNAs / antagonists & inhibitors*
  • Molecular Mimicry
  • Neoplasm Staging
  • Paclitaxel / therapeutic use*
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / metabolism*
  • S Phase
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / metabolism*
  • Up-Regulation

Substances

  • HOTAIR long untranslated RNA, human
  • MIRN217 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • Doxorubicin
  • Paclitaxel